FR2908892B1 - PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS - Google Patents

PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS

Info

Publication number
FR2908892B1
FR2908892B1 FR0610181A FR0610181A FR2908892B1 FR 2908892 B1 FR2908892 B1 FR 2908892B1 FR 0610181 A FR0610181 A FR 0610181A FR 0610181 A FR0610181 A FR 0610181A FR 2908892 B1 FR2908892 B1 FR 2908892B1
Authority
FR
France
Prior art keywords
activity
factor viii
chromogenic assay
plasmas
need
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0610181A
Other languages
French (fr)
Other versions
FR2908892A1 (en
Inventor
Jean Amiral
Anne Marie Vissac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyphen Biomed SAS
Original Assignee
Hyphen Biomed SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyphen Biomed SAS filed Critical Hyphen Biomed SAS
Priority to FR0610181A priority Critical patent/FR2908892B1/en
Publication of FR2908892A1 publication Critical patent/FR2908892A1/en
Application granted granted Critical
Publication of FR2908892B1 publication Critical patent/FR2908892B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4728Details alpha-Glycoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90287Oxidoreductases (1.) oxidising metal ions (1.16)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0610181A 2006-11-21 2006-11-21 PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS Expired - Fee Related FR2908892B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0610181A FR2908892B1 (en) 2006-11-21 2006-11-21 PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610181A FR2908892B1 (en) 2006-11-21 2006-11-21 PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS

Publications (2)

Publication Number Publication Date
FR2908892A1 FR2908892A1 (en) 2008-05-23
FR2908892B1 true FR2908892B1 (en) 2009-02-20

Family

ID=38222712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0610181A Expired - Fee Related FR2908892B1 (en) 2006-11-21 2006-11-21 PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS

Country Status (1)

Country Link
FR (1) FR2908892B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102798598A (en) * 2011-05-25 2012-11-28 兆科药业(合肥)有限公司 Method for detecting enzymatic activity of phospholipid-depending factor X activator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60186760A (en) * 1984-03-05 1985-09-24 Sekisui Chem Co Ltd Blood coagulation accelerator
CA2065370C (en) * 1990-07-12 2000-04-04 Hendrik Coenraad Hemker Factor viii:ca chromogenic assay
JPH08327631A (en) * 1995-06-01 1996-12-13 Eisai Co Ltd Reagent for measuring blood coagulation activity
DE69801210T2 (en) * 1998-03-19 2002-05-02 Instrumentation Laboratory S.P.A., Mailand/Milano Improved in vitro procedures, test kits and reagents for screening blood clotting defects
DK1194161T3 (en) * 1999-07-13 2006-02-13 Biovitrum Ab Stable factor VIII compositions

Also Published As

Publication number Publication date
FR2908892A1 (en) 2008-05-23

Similar Documents

Publication Publication Date Title
FR15C0046I2 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
FR2882654B1 (en) USE OF DIOSMETIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF THROMBOTIC DISEASES
FR13C0060I2 (en) FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
NO20034388D0 (en) Therapeutic agent for chronic arthritis diseases in child-related diseases
ES2983099T3 (en) Process for the concentration of antibodies and therapeutic products from them
FR2906808B1 (en) USE OF MONOCLONAL ANTIBODIES SPECIFIC TO THE O-ACETYLATED FORMS OF GANGLIOSIDE GD2 IN THE TREATMENT OF CERTAIN CANCERS
CL2007003155A1 (en) COMPOUNDS DERIVED FROM 3,7-DIAZABICICLO [3.3.0] OCTANO OR 3,7-DIAZABICICLO [3.3.1] NONANO, NEURONAL NICOTINIC RECEIVER MODULATORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CNS DISORDERS.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ATE512948T1 (en) BIPHENYL-SULFONYL AND PHENYL-HETEROARYL-SULFONYL MODULATORS OF THE HISTAMINE H3 RECEPTOR FOR THE TREATMENT OF RELATED DISEASES
FR2900734B1 (en) DETECTION OF THROMBOEMBOLIC VENOUS DISEASES BY THE ASSAY OF D-DIMERS AND SOLUBLE FIBRIN
FR2854074B1 (en) USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
FR2887141B1 (en) COMPRESSIVE ORTHESIS TRICOTEE OF THE LOWER MEMBER FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
FR2900157B1 (en) PROCESS FOR THE DESULFURATION OF OLEFINIC ESSENCES COMPRISING AT LEAST TWO DISTINCT HYDRODESULFURATION STAGES
ATE424823T1 (en) 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY
FR2891163B1 (en) CATALYST FOR THE PREPARATION OF PENTAFLUOROETHANE AND THE PROCESS OF PREPARATION THEREOF
FR2883182B1 (en) VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
ATE406895T1 (en) 4-PHENYL-5-OXO-L,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY
FR2919187B1 (en) USE OF YEAST SKIN FOR THE TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA.
FR2886852B1 (en) COMPOSITION BASED ON AVERMECTIN AND HYDROCORTISONE, IN PARTICULAR FOR THE TREATMENT OF ROSACEA
FR2889068B1 (en) NOVEL DAIRY PROTEIN FRACTIONS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY DISEASES
FR2903999B1 (en) MODULATORS OF SC4MOL IN THE TREATMENT OF ACNE OR HYPERSEBORRHEA
FR2908892B1 (en) PROCESS FOR THE CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY AND NEED FOR CHROMOGENIC ASSAY OF FACTOR VIII: C ACTIVITY IN PLASMAS OR THERAPEUTIC FRACTIONS
FR2911849B1 (en) PURIFYING THE PROCESSING AND BURNING OF TWO BOTTLES OR BOTTLES
FR2876375B1 (en) PROCESS FOR THE PREPARATION OF (METH) ACRYLIC ESTERS OR ANYDRIDES
DE602004010172D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY FUNCTIONAL DISORDERS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20220705